Google Search
A well-documented Business Plan aids in business funding and it is proven to help businesses grow by 30% faster.
Test Your Business ideas- We clear your doubts on Business concept and validate it properly. Often Businesses fail when the Business Plan is weak.
Market Research & High Industry Demand- We will analyse the Market Potential for optimal Industry Growth.
- Overview
- Stats
- Introduction
- Information
- Contact Us
- Project At A Glance
- Profitability And Net Cash Accruals
- Cost Of Project
- Asssessement Of Working Capital Requirements
- Profitability Ratios, Dscr, Debt Equity
- Break Even Analysis
- Means Of Finance
- Projected Balance Sheet
- Repayment Of Term Loan
- Debt Service Coverage Ratio
- Depreciation Chart
- Projected Pay-Back Period
- Projected Irr
- Company Summary
- Reasons For Buying The Report
- Our Approach
- Table Of Content
- Financial Plan
- Information/ Disclaimer
API Production. Manufacturing of Active Pharma Ingredients (API), Cephalexin, Ampicillin Trihydrate, Ibuprofen and Paracetamol.
API Production. Manufacturing of Active Pharma Ingredients (API), Cephalexin, Ampicillin Trihydrate, Ibuprofen and Paracetamol. API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. For example, an active ingredient to relieve pain is included in a painkiller. This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine. Related Projects:- Active Pharma Ingredients (api) The API form that is used in a formulation is often the most thermodynamically stable crystalline form. As such, the phenomenon of hydrogen bonding in combination with there being many functional groups on the API usually results in the available crystalline form being a hydrate. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Ampicillin is used to treat infections by many Gram-positive and Gram-negative bacteria. It was the first "broad spectrum" penicillin with activity against Gram-positive bacteria, including Streptococcus pneumonia, Streptococcus pyogenic, some isolates of Staphylococcus aureus (but not penicillin-resistant or methicillin-resistant strains), Trueperella, and some Enterococcus. Paracetamol is used for the relief of mild to moderate pain. The use of the intravenous form for short-term pain in people in the emergency department is supported by limited evidence. In adults it appears to be useful for migraines, tension headaches, perineal pain after childbirth, and kidney stone pain. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug class that is used for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. Market Outlook The production-linked incentive scheme - which accounts for INR0.9 billion of planned outlay - offers an incentive of up to 20% of sales for fermentation based products and up to 10% for chemical synthesis-based products for the next eight to nine years. This should help to bridge the price gap and make domestic production more competitive. The government has also allocated USD0.4 billion under the capex assistance scheme to fund up to 90% of the investment need to build common infrastructure facilities in three bulk drug parks. We believe this will aid the investment decisions of Indian pharma companies, particularly in the current environment where the focus in on conserving cash. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years. Active pharmaceutical ingredients are an active ingredient of any drug or tablet, which possesses medicinal properties. Some drugs with combined therapy have many active ingredients to treat different disorders. Related Videos: - Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 billion by 2023 Higher Growth in the APAC Active Pharmaceutical Ingredients Market Healthcare spending has witnessed continued growth for some time now. Even though the proportion of healthcare spending in the APAC region is comparatively low, the growth rate in this strategic region has outpaced that of mature markets in North America and Europe. Rising healthcare spending has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares to North America and Europe. Books:- BOOKS & DATABASES Huge investment promises from different countries predict a bright future for India. It has a well-developed administration and an independent judicial system with an ever-growing consumer base. It has a huge pool of hard-working skilled workers in all fields. The government has set up tax and non-tax incentives to establish new industrial entities in specific sectors, which include energy, ports, highways, electronics, and software. Related Videos:- Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit The global active pharmaceutical ingredients market has been broadly segmented based on manufacturer, APIs, drug, therapeutic, and region. In terms of manufacturer, the global market has been classified into in-house API manufacturing and API contract manufacturing. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years. Related Videos:- Manufacturing Business Ideas in Pharmaceutical Industry Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. Related Projects:- Startup Opportunities in Active Pharma Ingredients The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. Market Research Reports:- India Active Pharmaceutical Ingredient (API) The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Market Research:- Market Research Reports Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Related Projects: - Investment Opportunities in API Bulk Drugs & Intermediates Manufacturing Unit Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Related Projects:- Active Pharma Ingredients (api) (cephalexin, Ampicillin Trihydrate, Ibuprofen And Paracetamol) Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Related Projects: - Active Pharma Ingredients (API) Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Projects: - Project Reports & Profiles For More Details, Click Here: - Key players Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd. Sanofi India Ltd. Sri Krishna Pharmaceuticals Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd. Triton Laboratories Ltd. For More Details, Click Here: - https://bit.ly/32McBPb Tags:- #Activepharmaingredients #pharmaingredients #IndianPharma #medicineingredients #paracetamolingredients #amoxicillinTrihydrate #Azithromycin #COVID19 #Paracetamol #coronavirus #CoronavirusBusiness #COVID2019 #CaronaBUSINESS #lockdownbusiness #businessinlockdown #coronavirusbusiness #Entrepreneurs #covid19business #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #startupbusinessideas #businessestostart #startupideas #startupbusinesswithnomoney #businessstartupindia #API
| Plant capacity | Plant & machinery | Working capital | T.C.I | Return | Break even |
|---|---|---|---|---|---|
| - | - | - | - | 1% | 0% |
Introduction
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
| COST OF PROJECT | MEANS OF FINANCE | ||||||
|---|---|---|---|---|---|---|---|
| Particulars | Existing | Proposed | Total | Particulars | Existing | Proposed | Total |
| Land & Site Development Exp. | ********** | ********** | ********** | Capital | ********** | ********** | ********** |
| Buildings | ********** | ********** | ********** | Share Premium | ********** | ********** | ********** |
| Plant & Machineries | ********** | ********** | ********** | Other Type Share Capital | ********** | ********** | ********** |
| Motor Vehicles | ********** | ********** | ********** | Reserves & Surplus | ********** | ********** | ********** |
| Office Automation Equipments | ********** | ********** | ********** | Cash Subsidy | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | Internal Cash Accruals | ********** | ********** | ********** |
| Franchise & Other Deposits | ********** | ********** | ********** | Long/Medium Term Borrowings | ********** | ********** | ********** |
| Preliminary & Pre-operative Exp | ********** | ********** | ********** | Debentures / Bonds | ********** | ********** | ********** |
| Provision for Contingencies | ********** | ********** | ********** | Unsecured Loans/Deposits | ********** | ********** | ********** |
| Margin Money - Working Capital | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| Total | ********** | ********** | ********** | Total | ********** | ********** | ********** |
| PARTICULARS | OPERATING YEARS | ||||
|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| ********** | ********** | ********** | ********** | ********** | |
| Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
| Gross Sales Realisation | ********** | ********** | ********** | ********** | ********** |
| Less : Excise Duties/Levies | ********** | ********** | ********** | ********** | ********** |
| Net Sales Realisation | ********** | ********** | ********** | ********** | ********** |
| Total Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Expenses/Cost of Products/Services/Items | ********** | ********** | ********** | ********** | ********** |
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** |
| Indigenous | ********** | ********** | ********** | ********** | ********** |
| Total Nett Consumption | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** |
| Packing Material Cost | ********** | ********** | ********** | ********** | ********** |
| Sub Total of Net Consumption | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expenses | ********** | ********** | ********** | ********** | ********** |
| Depreciation | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance Exp. | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** |
| Cost of Output of Goods Sold | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Gross Profit | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
| Financial Charges | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowing | ********** | ********** | ********** | ********** | ********** |
| On Wkg. Capital Borrowings | ********** | ********** | ********** | ********** | ********** |
| Total Financial Charges | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** |
| Total Cost of Sales | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** |
| Tax on Profit | ********** | ********** | ********** | ********** | ********** |
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
| Depreciation Added Back | ********** | ********** | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
| Net Cash Accruals | ********** | ********** | ********** | ********** | ********** |
| PARTICULARS | EXISTING | PROPOSED | TOTAL |
|---|---|---|---|
| COST OF PROJECT | |||
| Land & Site Development Exp. | |||
| Land Area Required | ********** | ********** | ********** |
| Land Development Cost, Boundary Wall, Gate & Road etc. | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Buildings | ********** | ********** | ********** |
| Factory Building - | ********** | ********** | ********** |
| Office Buildings | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Plant & Machineries | ********** | ********** | ********** |
| Indigenous Machineries | ********** | ********** | ********** |
| Erection & Installation | ********** | ********** | ********** |
| Laboratory Equipments | ********** | ********** | ********** |
| Miscellaneous Equipments like pumps, valves, pipeline & fittings | ********** | ********** | ********** |
| Imported Machineries | ********** | ********** | ********** |
| Technical know how | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Office Vehicles | ********** | ********** | ********** |
| Office Automation Equipments (Telephone/ Fax/ Computer) | ********** | ********** | ********** |
| Office Equipment, Furniture plus Other Equipment & Accessories | ********** | ********** | ********** |
| Other Misc. Assets | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Pre-operative & Preliminary Expenses | ********** | ********** | ********** |
| Provision for Contingencies | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Total Capital Cost of Project | ********** | ********** | ********** |
| Margin Money for Working Capital | ********** | ********** | ********** |
| Total Cost of Project | ********** | ********** | ********** |
| PARTICULARS | STK.PRD. | STK.PRD. | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|---|---|
| 1st Year | 2nd Yr &+ | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
| Capacity | Months | Months | % | ********** | ********** | ********** | ********** | ********** |
| CURRENT ASSETS | ********** | ********** | ********** | ********** | ********** | |||
| Stocks on Hand | ********** | ********** | ********** | ********** | ********** | |||
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** | |||
| Indigenous | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Packing Material | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Consumable Store | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Work-in-Process | ********** | ********** | D | ********** | ********** | ********** | ********** | ********** |
| Finished Goods | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Current Expenses | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Receivables | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | ||
| Total | ********** | ********** | ********** | ********** | ********** | |||
| Cash/Bank Balances | ********** | ********** | ********** | ********** | ********** | |||
| Gross Wkg. Capital | ********** | ********** | ********** | ********** | ********** | |||
| PARTICULARS | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
| Profit Percentages to Net Sales | ||||||
| Gross Profit | ********** | ********** | ********** | ********** | ********** | |
| % Of G.P. to Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** | |
| % of N.P.B.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| % of N.P.A.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Coverage Ratio | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Coverage Ratio | ||||||
| Funds Available to Service Debts | ||||||
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
| Technical Knowhow Fees & Exp | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Obligations | ||||||
| Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ||
| D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Cumulative) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Overall) | ********** | ********** | ********** | ********** | ********** | |
| Parameters | ||||||
| Initial Equity Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Credit Balance in P & L | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Capital exclUnsec Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| Unsecured Dep. | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Equity incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowings from Bank | ********** | ********** | ********** | ********** | ********** | ********** |
| Term lia. Incl Unsecured Deposit | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Liabilities | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Liabilities incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| DEBT EQUITY RATIO considering | ********** | ********** | ********** | ********** | ********** | ********** |
| DEBT EQUITY RATIO considering | ||||||
| I.E.Total Term Lia./NW | ||||||
| Unsecured Dep. as Equity | ********** | ********** | ********** | ********** | ********** | ********** |
| Unsecured Dep. as Debt | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | |
| Assets Turnover Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
| No. of Shares of 10.00 each | ********** | ********** | ********** | ********** | ********** | |
| Earnings Per Share (EPS) (in) | ********** | ********** | ********** | ********** | ********** | |
| Proposed divident | ********** | ********** | ********** | ********** | ********** | |
| Cash EPS (in) | ********** | ********** | ********** | ********** | ********** | |
| Dividend Per Share(DPS) (in) | ********** | ********** | ********** | ********** | ********** | |
| Payout Ratio (%Age) | ********** | ********** | ********** | ********** | ********** | |
| Retained Earnings/Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Retained Earnings (%Age) | ********** | ********** | ********** | ********** | ********** | |
| Book Value Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Debt Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Probable Mkt. Price/Share(in) | ********** | ********** | ********** | ********** | ********** | |
| Price / Book Value (x) | ********** | ********** | ********** | ********** | ********** | |
| Price Earnings Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
| Yield (%Age) | ********** | ********** | ********** | ********** | ********** | |
| PARTICULARS | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|
| Ratio | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| BREAK EVEN ANALYSIS | ||||||
| Total Value of Output | ********** | ********** | ********** | ********** | ********** | |
| Variable Cost & Expenses | ||||||
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Packing Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Sales Commission/Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Sub-total | ********** | ********** | ********** | ********** | ********** | |
| Less: W.I.P. Adjustments | ********** | ********** | ********** | ********** | ********** | |
| Total Variable Cost | ********** | ********** | ********** | ********** | ********** | |
| Net Contribution | ********** | ********** | ********** | ********** | ********** | |
| Profit Volume Ratio (%) | ********** | ********** | ********** | ********** | ********** | |
| Semi-Var./Semi-Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Interest on Wkg.Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Semi-Var./Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Fixed Expenses / Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Intrest-Fixed Borrowing | ********** | ********** | ********** | ********** | ********** | ********** |
| Intrest-Working Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Deferred Expenses W/Off | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Fixed Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Fixed/Semi-Fixed Exp | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Cash Fixed/SemiFixed | ********** | ********** | ********** | ********** | ********** | ********** |
| Cash Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
| Cash Margin of Safety | ********** | ********** | ********** | ********** | ********** | ********** |
| Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
| Margin of safety | ********** | ********** | ********** | ********** | ********** | ********** |
| At Maximum Utilisation : | Year | ********** | ********** | ********** | ********** | ********** |
| (as % of Installed Capacity) | ||||||
| Cash B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
| B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
| MEANS OF FINANCE | |||
|---|---|---|---|
| Equity Share Capital | ********** | ********** | ********** |
| Others - Preference Share Capital | ********** | ********** | ********** |
| Total Equity Share Capital | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Long/Medium Term Borrowings | ********** | ********** | ********** |
| FROM BANK | ********** | ********** | ********** |
| From Other Financial Institutions | ********** | ********** | ********** |
| Total Long/Medium Term Borrowings | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Total Means of Finance | ********** | ********** | ********** |
| PARTICULARS | OPERATING YEARS | ||||
|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| Equity Share Capital | ********** | ********** | ********** | ********** | ********** |
| Surplus of Previous Year | ********** | ********** | ********** | ********** | ********** |
| Add : Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
| Surplus at the End of Year | ********** | ********** | ********** | ********** | ********** |
| Unsecured Deposits | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowings Proposed-FROM BANK | ********** | ********** | ********** | ********** | ********** |
| Bank Borrowing for Wkg. Capital | ********** | ********** | ********** | ********** | ********** |
| Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| Sundry Creditors | ********** | ********** | ********** | ********** | ********** |
| Other Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| Total Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Total of Liabilities | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| ASSETS | ********** | ********** | ********** | ********** | ********** |
| Fixed Assets | ********** | ********** | ********** | ********** | ********** |
| Gross Block | ********** | ********** | ********** | ********** | ********** |
| Less : Depreciation to Date | ********** | ********** | ********** | ********** | ********** |
| Net Block | ********** | ********** | ********** | ********** | ********** |
| Current Assets | ********** | ********** | ********** | ********** | ********** |
| Stocks on Hand | ********** | ********** | ********** | ********** | ********** |
| Receivables | ********** | ********** | ********** | ********** | ********** |
| Other Current Assets | ********** | ********** | ********** | ********** | ********** |
| Cash and Bank Balances | ********** | ********** | ********** | ********** | ********** |
| Total Current Assets | ********** | ********** | ********** | ********** | ********** |
| P & P Exp. and/or Other Dvp.Exp. | ********** | ********** | ********** | ********** | ********** |
| (To The Extent Not W/Off) | ********** | ********** | ********** | ********** | ********** |
| Other Non Current Assets | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Total of Assets | ********** | ********** | ********** | ********** | ********** |
| ROI (Average of Fixed Assets) | ********** | ********** | ********** | ********** | ********** |
| RONW (Average of Share Capital) | ********** | ********** | ********** | ********** | ********** |
| ROI (Average of Total Assets) | ********** | ********** | ********** | ********** | ********** |
INTEREST AND REPAYMENT ON TERM LOANS
| A | Name of Institution-Bank | ABC BANK | |
|---|---|---|---|
| B | Term Borrowing Amount | ********** | xx |
| C | Repayment Term (Years) | ********** | Years |
| D | Repayment Instalments | ********** | Instalments |
| E | Repayment Commencement | Year - 0; 3rd Qtr. | |
| F | Rate of Interest(General) | xxxx% | p.a. |
| G | Rate of Interest(Initial) | 0.00% | p.a. |
| H | Apply Gen. Int. Rate from Year | x Quarter :: x | |
| I | Interest Calculation | Quarterly |
| Debt Service Coverage Ratio | ||||||
|---|---|---|---|---|---|---|
| Funds Available to Service Debts | ||||||
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
| Technical Knowhow Fees & Expenses | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Obligations | ********** | ********** | ********** | ********** | ********** | |
| Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ||
| D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Cumulative) ..... | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Overall) ........ | ********** | ********** | ********** | ********** | ********** |
DEPRECIATION CHARGES AS PER BOOKS (TOTAL)
| Operating Year | F.Assets Type A-1 | F.Assets Type A-2 | F.Assets Type B | F.Assets Type C | F.Assets Type D-1 | F.Assets Type D-2 | Total |
|---|---|---|---|---|---|---|---|
| Particulars | Factory Building | Office Buildings | Plant & Machinery | Office Vehicles | Office Automation Equipments (Telephone/ Fax/ Computer) | Furniture & Fixtures | |
| 1-2 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 2-3 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 3-4 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 4-5 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 5-6 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| Particulars | Method | Deprn.Rate | Part Consideration (for Asset put to use less than xx months) |
|---|---|---|---|
| Type A :: Buildings | |||
| Factory Building - | WDV | ********** | ********** |
| Office Buildings | WDV | ********** | ********** |
| Type C | |||
| Office Vehicles | WDV | ********** | ********** |
| Type D :: Misc. Fixed Assets | |||
| Office Automation Equipments (Telephone/ Fax/ Computer) | WDV | ********** | ********** |
| Furniture & Fixtures | WDV | ********** | ********** |
| Type B :: Plant & Machineries |
| Projected Pay Back Period | |||||
|---|---|---|---|---|---|
| Particulars | Operating Years | ||||
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| Year | 1 | 2 | 3 | 4 | 5 |
| Initial Investment | ********* | ||||
| Total Initial Investment | ********* | ||||
| Yearly Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Pay Back Period | xx Years xx Months | xx Years xx months | |||
| Projected IRR | |||||
|---|---|---|---|---|---|
| Year | CFAT | PV factor @**% | ********* | ||
| Initial Investment | ********* | ********* | ********* | ||
| 1-2 | ********* | ********* | ********* | ||
| 2-3 | ********* | ********* | ********* | ||
| 3-4 | ********* | ********* | ********* | ||
| 4-5 | ********* | ********* | ********* | ||
| 5-6 | ********* | ********* | ********* | ||
| Total PV | ********* | ********* | |||
| IRR | ********* | ********* | |||
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.
Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.
NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.
- This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, demand of the product and reasons for investing in the product.
- This report provides vital information on the product like its definition, characteristics and segmentation.
- This report helps you market and place the product correctly by identifying the target customer group of the product.
- This report helps you understand the viability of the project by disclosing details like raw materials required, manufacturing process, project costs and snapshot of other project financials.
- The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decision.
- Our research reports broadly cover Indian markets, present analysis, outlook and forecast.
- The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players.
- We use reliable sources of information and databases. And information from such sources is processed by us and included in the report.
Introduction
- Project Introduction
- Project Objective and Strategy
- Concise History of the Product
- Properties
- BIS (Bureau of Indian Standards) Provision & Specification
- Uses & Applications
Market Study and Assessment
- Current Indian Market Scenario
- Present Market Demand and Supply
- Estimated Future Market Demand and Forecast
- Statistics of Import & Export
- Names & Addresses of Existing Units (Present Players)
- Market Opportunity
Raw Material
- List of Raw Materials
- Properties of Raw Materials
- Prescribed Quality of Raw Materials
- List of Suppliers and Manufacturers
Personnel (Manpower) Requirements
- Requirement of Staff & Labor (Skilled and Unskilled) Managerial, Technical, Office Staff and Marketing Personnel
Plant and Machinery
- List of Plant & Machinery
- Miscellaneous Items
- Appliances &Equipments
- Laboratory Equipments& Accessories
- Electrification
- Electric Load & Water
- Maintenance Cost
- Sources of Plant & Machinery (Suppliers and Manufacturers)
Manufacturing Process and Formulations
- Detailed Process of Manufacture with Formulation
- Packaging Required
- Process Flow Sheet Diagram
Infrastructure and Utilities
- Project Location
- Requirement of Land Area
- Rates of the Land
- Built Up Area
- Construction Schedule
- Plant Layout and Requirement of Utilities
- Assumptions for Profitability workings
- Plant Economics
- Production Schedule
-
- Land & Building
- Factory Land & Building
- Site Development Expenses
-
- Plant & Machinery
- Indigenous Machineries
- Other Machineries (Miscellaneous, Laboratory etc.)
-
- Other Fixed Assets
- Furniture & Fixtures
- Pre-operative and Preliminary Expenses
- Technical Knowhow
- Provision of Contingencies
-
- Working Capital Requirement Per Month
- Raw Material
- Packing Material
- Lab & ETP Chemical Cost
- Consumable Store
-
- Overheads Required Per Month And Per Annum
- Utilities & Overheads (Power, Water and Fuel Expenses etc.)
- Royalty and Other Charges
- Selling and Distribution Expenses
- Salary and Wages
- Turnover Per Annum
-
- Share Capital
- Equity Capital
- Preference Share Capital
- Annexure 1:: Cost of Project and Means of Finance
-
- Annexure 2:: Profitability and Net Cash Accruals
- Revenue/Income/Realisation
- Expenses/Cost of Products/Services/Items
- Gross Profit
- Financial Charges
- Total Cost of Sales
- Net Profit After Taxes
- Net Cash Accruals
-
- Annexure 3 :: Assessment of Working Capital requirements
- Current Assets
- Gross Working. Capital
- Current Liabilities
- Net Working Capital
- Working Note for Calculation of Work-in-process
- Annexure 4 :: Sources and Disposition of Funds
-
- Annexure 5 :: Projected Balance Sheets
- ROI (Average of Fixed Assets)
- RONW (Average of Share Capital)
- ROI (Average of Total Assets)
-
- Annexure 6 :: Profitability ratios
- D.S.C.R
- Earnings Per Share (EPS)
- Debt Equity Ratio
-
- Annexure 7 :: Break-Even Analysis
- Variable Cost & Expenses
- Semi-Var./Semi-Fixed Exp.
- Profit Volume Ratio (PVR)
- Fixed Expenses / Cost
- B.E.P
-
- Annexure 8 to 11:: Sensitivity Analysis-Price/Volume
- Resultant N.P.B.T
- Resultant D.S.C.R
- Resultant PV Ratio
- Resultant DER
- Resultant ROI
- Resultant BEP
-
- Annexure 12 :: Shareholding Pattern and Stake Status
- Equity Capital
- Preference Share Capital
-
- Annexure 13 :: Quantitative Details-Output/Sales/Stocks
- Determined Capacity P.A of Products/Services
- Achievable Efficiency/Yield % of Products/Services/Items
- Net Usable Load/Capacity of Products/Services/Items
- Expected Sales/ Revenue/ Income of Products/ Services/ Items
- Annexure 14 :: Product wise domestic Sales Realisation
- Annexure 15 :: Total Raw Material Cost
- Annexure 16 :: Raw Material Cost per unit
- Annexure 17 :: Total Lab & ETP Chemical Cost
- Annexure 18 :: Consumables, Store etc.,
- Annexure 19 :: Packing Material Cost
- Annexure 20 :: Packing Material Cost Per Unit
- Annexure 21 :: Employees Expenses
- Annexure 22 :: Fuel Expenses
- Annexure 23 :: Power/Electricity Expenses
- Annexure 24 :: Royalty & Other Charges
- Annexure 25 :: Repairs & Maintenance Exp.
- Annexure 26 :: Other Mfg. Expenses
- Annexure 27 :: Administration Expenses
- Annexure 28 :: Selling Expenses
- Annexure 29 :: Depreciation Charges – as per Books (Total)
- Annexure 30 :: Depreciation Charges – as per Books (P & M)
- Annexure 31 :: Depreciation Charges - As per IT Act WDV (Total)
- Annexure 32 :: Depreciation Charges - As per IT Act WDV (P & M)
- Annexure 33 :: Interest and Repayment - Term Loans
- Annexure 34 :: Tax on Profits
- Annexure 35 ::Projected Pay-Back Period And IRR
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
Need assistance?
Share your details, we will call you
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services.
Read more →Quick Links
Products & Services
Contact Info
| 106-E, Kamla Nagar,
New Delhi-110007, India. |
|
| +91 9097-075-054, +91-11-23843955, +91-11-23845886 Any quries? Call us. |
|
| [email protected]
Any quries? Mail Now. |
- Copyright © 2024 NPCS, All Right Reserved.
Let's Connect
Fill in the form below, &
we'll get back to you within 24 hours.